Status:
RECRUITING
Virtual Therapeutics for MCI
Lead Sponsor:
Istituto Auxologico Italiano
Collaborating Sponsors:
Istituto Superiore di Sanità
University of Turin, Italy
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Mild Cognitive Impairment (MCI) is a term used to describe the transitional stage that occurs between normal aging and the onset of dementia. Spatial disorientation is often considered a significant i...
Detailed Description
The current study aims to design, develop and test virtual therapeutics to train MCI spatial memory through virtual reality rehabilitation. 36 Participants will be randomly assigned to three different...
Eligibility Criteria
Inclusion
- a change in cognition recognized by patients or observers (Caregiver/examiner)
- an objective impairment in one or more cognitive domains using traditional neuropsychological tests;
- autonomy or slight dependence on daily life activities;
- absence of diagnosis of dementia
- absence of cognitive impairment measured by the mini-mental state examination;
- aged 65 or over
Exclusion
- the presence of acute stroke/transient ischemic attack occurred in the 6 months prior to the enrollment visit;
- the presence of aphasia and/or neglect;
- the presence of other concomitants severe neurological/psychiatric diseases (e.g., hemiparesis, multiple system atrophy, muscular skeletal/orthopedic deficits that limit movement)
- the presence of physical and/or functional deficits;
- the comorbidity with severe neurological and/or psychiatric diseases (e.g., neoplasms, multiple sclerosis, amyotrophic lateral sclerosis, Huntington's disease, schizophrenia, addiction, personality disorder, eating disorder) or with psychiatric conditions not under drug treatment (anxiety-depressive syndrome, bipolarism);
- the history of head trauma with loss of consciousness
- recurrent vertigo.
Key Trial Info
Start Date :
October 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06079411
Start Date
October 17 2023
End Date
July 1 2026
Last Update
March 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Auxologico Italiano
Milan, Lombardy, Italy, 20145